TLR4 and chronic kidney disease: Our findings showed that the atherogenic predictive power of endotoxin was significantly increased by the presence of elevated serum levels of inflammatory mediators in South African CKD patients and that TLR4 polymorphisms are associated with low levels of inflammatory markers and CIMT values.